| Value | ₹6.00 Cr |
|---|
NSE filing, NSE: INDIAMART. Summary written from the filing by ALFA Finder's alert engine.
IndiaMART InterMESH Ltd: key numbers
- Share price
- ₹1,544.20
- Market cap
- ₹9,287 Cr
- Revenue (annual)
- ₹1,569 Cr
- Net profit (annual)
- ₹474.7 Cr
- P/E (TTM)
- 18.5×Sector 60.2×
- Promoter holding
- 49.07%+0.00% QoQ
- FII holding
- 20.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IndiaMART InterMESH Ltd
All →IndiaMART InterMESH Results Update
IndiaMART InterMESH reported Q2 FY27 consolidated revenue of ₹429 Crore, up 10% YoY, with net profit of ₹91 Crore. EBITDA margin stood at 37% on a consolidated basis.
IndiaMART InterMESH Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹429 Cr (+10% YoY), EBITDA ₹159 Cr (37% margin), PAT ₹91 Cr (+10%). Standalone PAT ₹106 Cr (+27%).
IndiaMART InterMESH Q2 FY27 Results: Net Profit ₹90.7 Cr, Up 9.8% YoY
IndiaMART InterMESH Ltd reported revenue from operations of ₹428.6 Cr (+9.6% YoY) and net profit of ₹90.7 Cr (+9.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.7 Cr · +9.8% YoY
IndiaMART InterMESH Q2 FY27 Results: Net Profit ₹90.8 Cr, Up 9.8% YoY
IndiaMART InterMESH Ltd reported revenue from operations of ₹428.6 Cr (+9.6% YoY) and net profit of ₹90.8 Cr (+9.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.8 Cr · +9.8% YoY
IndiaMART InterMESH Board Meeting Date
IndiaMART InterMESH Ltd will hold a board meeting on October 27, 2026, to approve its financial results for the quarter and half-year ended September 30, 2026.
IndiaMART InterMESH Other Announcement
IndiaMART InterMESH Limited has submitted its quarterly shareholding pattern disclosure as per SEBI Regulation 31 requirements.
Other financial results announcements
All →Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Bandaram Pharma Packtech Q2 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY